Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wacker

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Chemmedchem|April 5, 2012
Identification of selective inhibitors of the potassium channel Kv1.1-1.2((3)) by high-throughput virtual screening and automated patch clampSören J Wacker, Wiktor Jurkowski, Katie J Simmons, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 4, 2020
Trimethylamine-<i>N</i>-oxide acutely increases cardiac muscle contractilityCarlee I Oakley, Julian A Vallejo, Derek Wang, et al.
The Journal of Surgical Research|August 27, 2024
Fat Embolism Does Not Alter Cardiac Structure or Induce Pathological Changes in a Rat ModelShaan Patel, Rohan Ahuja, Julian A Vallejo, et al.
Structure (London, England : 1993)|May 9, 2008
The molecular mechanism of toxin-induced conformational changes in a potassium channel: relation to C-type inactivationUlrich Zachariae, Robert Schneider, Phanindra Velisetty, et al.
Swiss Medical Weekly|April 24, 2002
Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory SocietyE W Russi, P Leuenberger, O Brändli, et al.
Bone Research|March 2, 2019
Characterization of a novel murine Sost ER<sup>T2</sup> Cre model targeting osteocytesDelphine B Maurel, Tsutomu Matsumoto, Julian A Vallejo, et al.
Scientific Reports|May 18, 2017
FGF23/FGFR4-mediated left ventricular hypertrophy is reversibleAlexander Grabner, Karla Schramm, Neerupma Silswal, et al.
The Journal of Biological Chemistry|October 16, 2010
Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) potentiates cardiac contractility via activation of the ryanodine receptorChad D Touchberry, Ian K Bales, Jessica K Stone, et al.
American Journal of Physiology. Renal Physiology|May 16, 2019
MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the <i>cpk</i> model of polycystic kidney diseaseSally M Salah, James D Meisenheimer, Reena Rao, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 28, 2013
FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophyChad D Touchberry, Troy M Green, Vladimir Tchikrizov, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Chemmedchem|April 5, 2012
Identification of selective inhibitors of the potassium channel Kv1.1-1.2((3)) by high-throughput virtual screening and automated patch clampSören J Wacker, Wiktor Jurkowski, Katie J Simmons, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 4, 2020
Trimethylamine-<i>N</i>-oxide acutely increases cardiac muscle contractilityCarlee I Oakley, Julian A Vallejo, Derek Wang, et al.
The Journal of Surgical Research|August 27, 2024
Fat Embolism Does Not Alter Cardiac Structure or Induce Pathological Changes in a Rat ModelShaan Patel, Rohan Ahuja, Julian A Vallejo, et al.
Structure (London, England : 1993)|May 9, 2008
The molecular mechanism of toxin-induced conformational changes in a potassium channel: relation to C-type inactivationUlrich Zachariae, Robert Schneider, Phanindra Velisetty, et al.
Swiss Medical Weekly|April 24, 2002
Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory SocietyE W Russi, P Leuenberger, O Brändli, et al.
Bone Research|March 2, 2019
Characterization of a novel murine Sost ER<sup>T2</sup> Cre model targeting osteocytesDelphine B Maurel, Tsutomu Matsumoto, Julian A Vallejo, et al.
Scientific Reports|May 18, 2017
FGF23/FGFR4-mediated left ventricular hypertrophy is reversibleAlexander Grabner, Karla Schramm, Neerupma Silswal, et al.
The Journal of Biological Chemistry|October 16, 2010
Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) potentiates cardiac contractility via activation of the ryanodine receptorChad D Touchberry, Ian K Bales, Jessica K Stone, et al.
American Journal of Physiology. Renal Physiology|May 16, 2019
MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the <i>cpk</i> model of polycystic kidney diseaseSally M Salah, James D Meisenheimer, Reena Rao, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 28, 2013
FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophyChad D Touchberry, Troy M Green, Vladimir Tchikrizov, et al.
Pageof 12